809 related articles for article (PubMed ID: 30764782)
1. Revisiting racial differences in ESRD due to ADPKD in the United States.
Murphy EL; Dai F; Blount KL; Droher ML; Liberti L; Crews DC; Dahl NK
BMC Nephrol; 2019 Feb; 20(1):55. PubMed ID: 30764782
[TBL] [Abstract][Full Text] [Related]
2. Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: results from the 1997 ESRD Core Indicators Project. National ESRD Core Indicators Workgroup.
Rocco MV; Frankenfield DL; Frederick PR; Pugh J; McClellan WM; Owen WF
Perit Dial Int; 2000; 20(3):328-35. PubMed ID: 10898051
[TBL] [Abstract][Full Text] [Related]
3. Differences in survival between black and white patients with diabetic end-stage renal disease.
Cowie CC; Port FK; Rust KF; Harris MI
Diabetes Care; 1994 Jul; 17(7):681-7. PubMed ID: 7924777
[TBL] [Abstract][Full Text] [Related]
4. Racial variation in autosomal dominant polycystic kidney disease.
Freedman BI; Soucie JM; Chapman A; Krisher J; McClellan WM
Am J Kidney Dis; 2000 Jan; 35(1):35-9. PubMed ID: 10620541
[TBL] [Abstract][Full Text] [Related]
5. Higher protein intake is associated with increased risk for incident end-stage renal disease among blacks with diabetes in the Southern Community Cohort Study.
Malhotra R; Cavanaugh KL; Blot WJ; Ikizler TA; Lipworth L; Kabagambe EK
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1079-1087. PubMed ID: 27562875
[TBL] [Abstract][Full Text] [Related]
6. Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Nee R; Martinez-Osorio J; Yuan CM; Little DJ; Watson MA; Agodoa L; Abbott KC
Am J Kidney Dis; 2015 Oct; 66(4):630-7. PubMed ID: 26002293
[TBL] [Abstract][Full Text] [Related]
7. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
[TBL] [Abstract][Full Text] [Related]
8. Mortality risk in patients with autosomal dominant polycystic kidney disease.
Mladsi D; Zhou X; Mader G; Sanon M; Wang J; Barnett C; Willey C; Seliger S
BMC Nephrol; 2024 Feb; 25(1):56. PubMed ID: 38365638
[TBL] [Abstract][Full Text] [Related]
9. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors.
Li S; McAlpine DD; Liu J; Li S; Collins AJ
Adv Ren Replace Ther; 2004 Jan; 11(1):5-13. PubMed ID: 14730534
[TBL] [Abstract][Full Text] [Related]
10. The joint effects of race and age on the risk of end-stage renal disease attributed to hypertension.
Lopes AA; Hornbuckle K; James SA; Port FK
Am J Kidney Dis; 1994 Oct; 24(4):554-60. PubMed ID: 7942809
[TBL] [Abstract][Full Text] [Related]
11. Racial differences in the incidence of end-stage renal disease.
Tell GS; Hylander B; Craven TE; Burkart J
Ethn Health; 1996 Mar; 1(1):21-31. PubMed ID: 9395545
[TBL] [Abstract][Full Text] [Related]
12. Incidence and predictors of end stage renal disease among low-income blacks and whites.
Lipworth L; Mumma MT; Cavanaugh KL; Edwards TL; Ikizler TA; Tarone RE; McLaughlin JK; Blot WJ
PLoS One; 2012; 7(10):e48407. PubMed ID: 23110237
[TBL] [Abstract][Full Text] [Related]
13. Relationships of race and ethnicity to progression of kidney dysfunction and clinical outcomes in patients with chronic kidney failure.
Lopes AA
Adv Ren Replace Ther; 2004 Jan; 11(1):14-23. PubMed ID: 14730535
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic analysis of selected intermediate outcomes for hemodialysis patients: results from the 1997 ESRD Core Indicators Project.
Frankenfield DL; Rocco MV; Frederick PR; Pugh J; McClellan WM; Owen WF
Am J Kidney Dis; 1999 Oct; 34(4):721-30. PubMed ID: 10516355
[TBL] [Abstract][Full Text] [Related]
15. The relationship of age, race, and ethnicity with survival in dialysis patients.
Yan G; Norris KC; Yu AJ; Ma JZ; Greene T; Yu W; Cheung AK
Clin J Am Soc Nephrol; 2013 Jun; 8(6):953-61. PubMed ID: 23539227
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States.
Hsu CY; Lin F; Vittinghoff E; Shlipak MG
J Am Soc Nephrol; 2003 Nov; 14(11):2902-7. PubMed ID: 14569100
[TBL] [Abstract][Full Text] [Related]
17. The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors.
Brancati FL; Whittle JC; Whelton PK; Seidler AJ; Klag MJ
JAMA; 1992 Dec; 268(21):3079-84. PubMed ID: 1433738
[TBL] [Abstract][Full Text] [Related]
18. Risk of ESRD in the United States.
Albertus P; Morgenstern H; Robinson B; Saran R
Am J Kidney Dis; 2016 Dec; 68(6):862-872. PubMed ID: 27578184
[TBL] [Abstract][Full Text] [Related]
19. Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States.
McGill RL; Saunders MR; Hayward AL; Chapman AB
Clin J Am Soc Nephrol; 2022 Jul; 17(7):976-985. PubMed ID: 35725555
[TBL] [Abstract][Full Text] [Related]
20. Incidence of treatment for end-stage renal disease attributed to diabetes mellitus, by race/ethnicity--Colorado, 1982-1989.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1992 Nov; 41(44):845-8. PubMed ID: 1435671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
